Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 11, 2012, Pages 3866-3875

  Bertagna, Francesco ^a   Treglia, Giorgio ^b   Piccardo, Arnoldo ^c   Giubbini, Raffaele ^a  

^a SPEDALI CIVILI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c GALLIERA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DUAL TIME POINT POSITRON EMISSION TOMOGRAPHY; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; INCIDENCE; MALIGNANT TRANSFORMATION; NEEDLE BIOPSY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; REFERENCE VALUE; REVIEW; RISK ASSESSMENT; STANDARD UPTAKE VALUE; SYSTEMATIC REVIEW; THYROID INCIDENTALOMA; THYROID NODULE;

FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENTAL FINDINGS; POSITRON-EMISSION TOMOGRAPHY; THYROID GLAND; THYROID NEOPLASMS;

EID: 84868629208     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2390     Document Type: Review

References (78)

1. DeGroot LJ, Kaplan EL, McCormick M, Straus FH 1990 Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424
2. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306 (Pubitemid 28065257)
3. Stokkel MP, Duchateau CS, Dragoiescu C 2006 The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature. Q J Nucl Med Mol Imaging 50:78-87
4. Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, Tennvall J, Bombardieri E 2008 European Association of Nuclear Medicine (EANM). Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 35:1941-1959
5. Bertagna F, Bosio G, Biasiotto G, Rodella C, Puta E, Gabanelli S, Lucchini S, Merli G, Savelli G, Giubbini R, Rosenbaum J, Alavi A 2009 F-18 FDG-PET/CT evaluation of patients with differentiated thyroid cancer with negative I-131 total body scan and high thyroglobulin level. Clin Nucl Med 34:756-761
6. Dong MJ, Liu ZF, Zhao K, Ruan LX, Wang GL, Yang SY, Sun F, Luo XG 2009 Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis. Nucl Med Commun 30:639-650
7. Mian C, Barollo S, Pennelli G, Pavan N, Rugge M, Pelizzo MR, Mazzarotto R, Casara D, Nacamulli D, Mantero F, Opocher G, Busnardo B, Girelli ME 2008 Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake. Clin Endocrinol (Oxf) 68:108-116 (Pubitemid 350243490)
8. Bertagna F, Giubbini R 2011 F18-FDG PET/CT and differentiated thyroid carcinoma: a critical and still debated issue. Ann Surg Oncol 18(Suppl 3):S304-S305
9. Burguera B, Gharib H 2000 Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am 29:187-203
10. Iyer NG, Shaha AR, Silver CE, Devaney KO, Rinaldo A, Pellitteri PK, Ferlito A 2010 Thyroid incidentalomas: to treat or not to treat. Eur Arch Otorhinolaryngol 267:1019-1026
11. Katz SC, Shaha A 2008 PET-associated incidental neoplasms of the thyroid. J Am Coll Surg 207:259-264
12. Salvatori M, Melis L, Castaldi P, Maussier ML, Rufini V, Perotti G, Rubello D 2007 Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography. Biomed Pharmacother 61:488-493 (Pubitemid 47385091)
13. Are C, Hsu JF, Schoder H, Shah JP, Larson SM, Shaha AR 2007 FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol 14:239-247 (Pubitemid 44954295)
14. Are C, Hsu JF, Ghossein RA, Schoder H, Shah JP, Shaha AR 2007 Histological aggressiveness of fluoro deoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas. Ann Surg Oncol 14:3210-3215 (Pubitemid 47594286)
15. Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, Moley JF 2001 Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 130:941-946 (Pubitemid 34014558)
16. Chen YK, Ding HJ, Chen KT, Chen YL, Liao AC, Shen YY, Su CT, Kao CH 2005 Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 25:1421-1426 (Pubitemid 40546824)
17. Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, Baek CH, Chung JH, Lee KH, Kim BT 2006 Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med 47:609-615 (Pubitemid 46772890)
18. Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK 2005 18F-Fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 115:1074-1078 (Pubitemid 40777005)
19. Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Collins DA, Kasperbauer JL, Strome SE, Reading CC, Hay ID, Lowe VJ 2007 The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl Med Commun 28:373-381 (Pubitemid 46569170)
20. Chu QD, Connor MS, Lilien DL, Johnson LW, Turnage RH, Li BD 2006 Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center. Am Surg 72:272-275 (Pubitemid 351837710)
21. Nishimori H, Tabah R, Hickeson M, How J 2011 Incidental thyroid "PETomas": clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake. Can J Surg 54:83-88
22. Ishimori T, Patel PV, Wahl RL 2005 Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 46:752-757
23. Kang KW, Kim SK, Kang HS, Lee ES, Sim JS, Lee IG, Jeong SY, Kim SW 2003 Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 88:4100-4104 (Pubitemid 37153705)
24. Nilsson IL, Arnberg F, Zedenius J, Sundin A 2011 Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/computed tomography: practical management algorithm. World J Surg 35:2691-2697
25. Ho TY, Liou MJ, Lin KJ, Yen TC 2011 Prevalence and significance of thyroid uptake detected by 18F-FDG PET. Endocrine 40:297-302
26. Kim BH, Na MA, Kim IJ, Kim SJ, Kim YK 2010 Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Ann Nucl Med 24:721-728
27. Pagano L, Samà MT, Morani F, Prodam F, Rudoni M, Boldorini R, Valente G, Marzullo P, Baldelli R, Appetecchia M, Isidoro C, Aimaretti G 2011 Thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol (Oxf) 75:528-534
28. Bae JS, Chae BJ, Park WC, Kim JS, Kim SH, Jung SS, Song BJ 2009 Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer. World J Surg Oncol 7:63
29. Zhai G, Zhang M, Xu H, Zhu C, Li B 2010 The role of 18F- fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma. J Endocrinol Invest 33:151-155
30. King DL, Stack Jr BC, Spring PM, Walker R, Bodenner DL 2007 Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. Otolaryngol Head Neck Surg 137:400-404 (Pubitemid 47320854)
31. Nam SY, Roh JL, Kim JS, Lee JH, Choi SH, Kim SY 2007 Focal uptake of (18)F fluorodeoxyglucose by thyroid in patients with non-thyroidal head and neck cancers. Clin Endocrinol (Oxf) 67:135-139 (Pubitemid 46955453)
32. Even-Sapir E, Lerman H, Gutman M, Lievshitz G, Zuriel L, Polliack A, Inbar M, Metser U 2006 The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT. Eur J Nucl Med Mol Imaging 33:541-552
33. Ohba K, Nishizawa S, Matsushita A, Inubushi M, Nagayama K, Iwaki H, Matsunaga H, Suzuki S, Sasaki S, Oki Y, Okada H, Nakamura H 2010 High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodeoxyglucose [corrected] positron emission tomography in relatively young healthy subjects: results of 3-year follow-up. Endocr J 57:395-401
34. Kwak JY, Kim EK, Yun M, Cho A, Kim MJ, Son EJ, Oh KK 2008 Thyroid incidentalomas identified by 18F-FDG PET: sonographic correlation. AJR Am J Roentgenol 191:598-603
35. Hsieh H, Lin S, Yang B, Chu Y, Chang C, Liu R 2003 The clinical relevance of thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography. Ann Nucl Med Sci 16:53-58
36. Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A 2009 Evaluation of thyroid FDG uptake incidentally identified on FDGPET/ CT imaging. Nucl Med Commun 30:240-244
37. Eloy JA, Brett EM, Fatterpekar GM, Kostakoglu L, Som PM, Desai SC, Genden EM 2009 The significance and management of incidental [18F]fluorodeoxyglucose- positron-emission tomography uptake in the thyroid gland in patients with cancer. AJNR Am J Neuroradiol 30:1431-1434
38. Kang BJ, O JH, Baik JH, Jung SL, Park YH, Chung SK 2009 Incidental thyroid uptake on F-18 FDG PET/CT: correlation with ultrasonography and pathology. Ann Nucl Med 23:729-737
39. Bonabi S, Schmidt F, Broglie MA, Haile SR, Stoeckli SJ 2 February 2012 Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact. Eur Arch Otorhinolaryngol doi:10.1007/s00405-012-1941-7
40. Pampaloni MH, Win AZ 2012 Prevalence and characteristics of incidentalomas discovered by whole body FDG PET CT. Int J Mol Imaging 2012:476763
41. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM; American Thyroid Association Guidelines Taskforce 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142
42. Leboeuf R, Bénard F, Langlois MF 2006 Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid. Clin Nucl Med 31:382-385 (Pubitemid 44315516)
43. Noordzij MJ, de Heide LJ, Links TP, Jager PL, Wolfenbuttel BH 2007 Four patients with incidentalomas of the thyroid discovered on 18-fluoro-deoxyglucose positron-emission tomography (FDG-PET).Ned Tijdschr Geneeskd 151:2337-2341 (Pubitemid 350056858)
44. Prichard RS, Cotter M, Evoy D, Gibbons D, Collins C, McDermott E, Skehan S 2011 Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation. Ir Med J 104:177-179
45. Vriens D, de Wilt JH, van der Wilt GJ, Netea-Maier RT, Oyen WJ, de Geus-Oei LF 2011 The role of [(18) F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer 117:4582-4594
46. Kresnik E, Gallowitsch HJ, Mikosch P, Stettner H, Igerc I, Gomez I, Kumnig G, Lind P 2003 Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery 133:294-299 (Pubitemid 36390792)
47. de Geus-Oei LF, Pieters GF, Bonenkamp JJ, Mudde AH, Bleeker-Rovers CP, Corstens FH, Oyen WJ 2006 18F FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results. J Nucl Med 47:770-775 (Pubitemid 46768439)
48. Sebastianes FM, Cerci JJ, Zanoni PH, Soares Jr J, Chibana LK, Tomimori EK, de Camargo RY, Izaki M, Giorgi MC, Eluf-Neto J, Meneghetti JC, Pereira MA 2007 Role of 18F fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab 92:4485-4488 (Pubitemid 350074775)
49. Hales NW, Krempl GA, Medina JE 2008 Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? Am J Otolaryngol 29:113-118 (Pubitemid 351296350)
50. Traugott AL, Dehdashti F, Trinkaus K, Cohen M, Fialkowski E, Quayle F, Hussain H, Davila R, Ylagan L, Moley JF 2010 Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis. World J Surg 34:1247-1253
51. Kim JM, Ryu JS, Kim TY, Kim WB, Kwon GY, Gong G, Moon DH, Kim SC, Hong SJ, Shong YK 2007 18F-Fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J Clin Endocrinol Metab 92:1630-1634 (Pubitemid 46997163)
52. Giovanella L, Suriano S, Maffioli M, Ceriani L 2011 18FDG-positron emission tomography/computed tomography (PET/CT) scanning in thyroid nodules with nondiagnostic cytology. Clin Endocrinol (Oxf) 74:644-648
53. Amir A, Karls S, Sands N, Forest VI, Hier M, Gologan O, Payne R 2011 Value of thyroid incidentalomas on positron emission tomographic scans among thyroidectomy patients. J Otolaryngol Head Neck Surg 40:391-395
54. Deandreis D, Al Ghuzlan A, Auperin A, Vielh P, Caillou B, Chami L, Lumbroso J, Travagli JP, Hartl D, Baudin E, Schlumberger M, Leboulleux S 2012 Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid 22:165-172
55. Shie P, Cardarelli R, Sprawls K, Fulda KG, Taur A 2009 Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun 30:742-748
56. Feine U, Lietzenmayer R, Hanke JP, Held J, Wöhrle H, Müller-Schauenburg W 1996 Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 37:1468-1472 (Pubitemid 26321624)
57. Wang W, Macapinlac H, Larson SM, Yeh SD, Akhurst T, Finn RD, Rosai J, Robbins RJ 1999 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab 84:2291-2302
58. Grabellus F, Nagarajah J, Bockisch A, Schmid KW, Sheu SY 2012 Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma. Clin Nucl Med 37:121-127
59. Choi JW, Yoon YH, Yoon YH, Kim SM, Koo BS 2011 Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT. Ann Surg Oncol 18:1306-1311
60. Morani F, Pagano L, Prodam F, Aimaretti G, Isidoro C 2012 Loss of expression of the oncosuppressor PTEN in thyroid incidentalomas associates with GLUT1 plasma membrane expression. Panminerva Med 54:59-63
61. Bloom AD, Adler LP, Shuck JM 1993 Determination of malignancy of thyroid nodules with positron emission tomography. Surgery 114:728-734, discussion 734-735
62. Mitchell JC, Grant F, Evenson AR, Parker JA, Hasselgren PO, Parangi S 2005 Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. Surgery 138:1166-1174, discussion 1174-1175
63. Sobrinho-Simões MA, Nesland JM, Holm R, Sambade MC, Johannessen JV 1985 Hürthle cell and mitochondrion-rich papillary carcinomas of the thyroid gland: an ultrastructural and immunocytochemical study. Ultrastruct Pathol 8:131-142
64. Döbert N, Hamscho N, Menzel C, Neuss L, Kovács AF, Grünwald F 2004 Limitations of dual time point FDG-PET imaging in the evaluation of focal abdominal lesions. Nuklearmedizin 43:143-149 (Pubitemid 39456602)
65. Barger Jr RL, Nandalur KR 2012 Diagnostic performance of dualtime (18)F-FDG PET in the diagnosis of pulmonary nodules: a meta-analysis. Acad Radiol 19:153-158
66. Choi WH, Yoo IR, O JH, Kim SH, Chung SK 2011 The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients. Br J Radiol 84:593-599
67. Lee JW, Kim SK, Lee SM, Moon SH, Kim TS 2011 Detection of hepatic metastases using dual-time-point FDG PET/CT scans in patients with colorectal cancer. Mol Imaging Biol 13:565-572
68. Dirisamer A, Halpern BS, Schima W, Heinisch M, Wolf F, Beheshti M, Dirisamer F, Weber M, Langsteger W 2008 Dual-time-point FDG-PET/CT for the detection of hepatic metastases. Mol Imaging Biol 10:335-340
69. Uesaka D, Demura Y, Ishizaki T, Ameshima S, Miyamori I, Sasaki M, Fujibayashi Y, Okazawa H 2008 Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer. J Nucl Med 49:1606-1612
70. Matthies A, Hickeson M, Cuchiara A, Alavi A 2002 Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 43:871-875 (Pubitemid 34747808)
71. Sanghera B, Wong WL, Lodge MA, Hain S, Stott D, Lowe J, Lemon C, Goodchild K, Saunders M 2005 Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer. Nucl Med Commun 26:861-867 (Pubitemid 41426547)
72. Mavi A, Basu S, Cermik TF, Urhan M, Bathaii M, Thiruvenkatasamy D, Houseni M, Dadparvar S, Alavi A 2009 Potential of dual time point FDG-PET imaging in differentiating malignant from benign pleural disease. Mol Imaging Biol 11:369-378
73. Kumar R, Loving VA, Chauhan A, Zhuang H, Mitchell S, Alavi A 2005 Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET. J Nucl Med 46:1819-1824 (Pubitemid 46196643)
74. Nishiyama Y, Yamamoto Y, Fukunaga K, Kimura N, Miki A, Sasakawa Y, Wakabayashi H, Satoh K, Ohkawa M 2006 Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma. J Nucl Med 47:633-638 (Pubitemid 46768464)
75. Tian R, Su M, Tian Y, Li F, Li L, Kuang A, Zeng J 2009 Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions. Skeletal Radiol 38:451-458
76. Hsiao YC, Wu PS, Chiu NT, Yao WJ, Lee BF, Peng SL 2011 The use of dual-phase F18-FDG PET in characterizing thyroid incidentalomas. Clin Radiol 66:1197-1202
77. Kim SJ, Kim BH, Jeon YK, Kim SS, Kim IJ 2011 Limited diagnostic and predictive values of dual-time-point 18F FDG PET/CT for differentiation of incidentally detected thyroid nodules. Ann Nucl Med 25:347-353
78. D'Souza MM, Marwaha RK, Sharma R, Jaimini A, Thomas S, Singh D, Jain M, Bhalla PJ, Tripathi M, Tiwari A, Mishra A, Mondal A, Tripathi RP 2010 Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography. Ann Nucl Med 24:345-355